BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 11344186)

  • 1. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
    Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
    Carella C; Mazziotti G; Morisco F; Rotondi M; Cioffi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    Eur J Endocrinol; 2002 Jun; 146(6):743-9. PubMed ID: 12039693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
    Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
    J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature.
    Nagayama Y; Ohta K; Tsuruta M; Takeshita A; Kimura H; Hamasaki K; Ashizawa K; Nakata K; Yokoyama N; Nagataki S
    Endocr J; 1994 Oct; 41(5):565-72. PubMed ID: 7889118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
    Krupińska J; Wawrzynowicz-Syczewska M; Urbanowicz W; Pobłocki J; Syrenicz A
    Endokrynol Pol; 2011; 62(6):517-22. PubMed ID: 22144218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
    Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
    Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of thyroid autoantibodies in pregnancy: the importance of test timing.
    Ekinci EI; Chiu WL; Lu ZX; Sikaris K; Churilov L; Bittar I; Lam Q; Crinis N; Houlihan CA
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):604-10. PubMed ID: 25079145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interferon-gamma therapy on thyroid function, T-lymphocyte subpopulations and induction of autoantibodies.
    Kung AW; Jones BM; Lai CL
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1230-4. PubMed ID: 2121769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration.
    Caraccio N; Dardano A; Manfredonia F; Manca L; Pasquali L; Iudice A; Murri L; Ferrannini E; Monzani F
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4133-7. PubMed ID: 15811929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients treated with interferon-alpha, interferon-beta, and interleukin-2 have a different thyroid autoantibody pattern than patients suffering from endogenous autoimmune thyroid disease.
    Schuppert F; Rambusch E; Kirchner H; Atzpodien J; Kohn LD; von zur Mühlen A
    Thyroid; 1997 Dec; 7(6):837-42. PubMed ID: 9459625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between iodine intake and thyroid autoantibodies: a cross-sectional study of 7073 early pregnant women in an iodine-adequate region.
    Sun J; Teng D; Li C; Peng S; Mao J; Wang W; Xie X; Fan C; Li C; Meng T; Zhang S; Du J; Gao Z; Shan Z; Teng W
    J Endocrinol Invest; 2020 Jan; 43(1):43-51. PubMed ID: 31264141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study.
    Durelli L; Ferrero B; Oggero A; Verdun E; Ghezzi A; Montanari E; Zaffaroni M;
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3525-32. PubMed ID: 11502774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
    Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters.
    Kasagi K; Takahashi N; Inoue G; Honda T; Kawachi Y; Izumi Y
    Thyroid; 2009 Sep; 19(9):937-44. PubMed ID: 19678737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of endocrine autoantibodies in chronic hepatitis C, before and after interferon-alpha therapy.
    Murdolo G; Francisci D; Forini F; Baldelli F; Angeletti G; Stagni G; Santeusanio F; Calcinaro F; Falorni A
    J Endocrinol Invest; 2002 Dec; 25(11):938-46. PubMed ID: 12553552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
    Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
    J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
    Doi F; Kakizaki S; Takagi H; Murakami M; Sohara N; Otsuka T; Abe T; Mori M
    Liver Int; 2005 Apr; 25(2):242-6. PubMed ID: 15780045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.